Treatment outcome according to tumor RAS mutation status in CRYSTAL study patients with metastatic colorectal cancer (mCRC) randomized to FOLFIRI with/without cetuximab

Authors :: Fortunato Ciardiello
Heinz-Josef Lenz
Claus-Henning Kohne
Volker Heinemann
Sabine Tejpar
Ivan Melezinek
Frank Beier
Christopher Stroh
Eric Van Cutsem
Source :: Journal of Clinical Oncology. 32:3506-3506
Publication Year :: 2014
Publisher :: American Society of Clinical Oncology (ASCO), 2014.

Tools